The approval of high doses (3.0mg and 4.5mg) will enable patients with type 2 diabetes treated with Trulicity to benefit from additional blood sugar and weight loss as the disease progresses." Trulicity is a glucagon-like peptide-1 (GLP-1) receptor agonist (RA), injected once a week, which has also been approved, combined with diet control and exercise, for the improvement of adult patients with type 2 diabetes Blood sugar control
The same is true for antipsychotics, anxiolytics, and antiepileptic/mood stabilizer medications
Wei Z, Li X, Zhou J, Zhou Y, Xiao Z, Yang Q
Abbreviations : DDI, drug-drug interaction
Where we need to be careful is if patients experience impaction because our bodies were designed to get rid of waste
Patients older than 65 experienced what Bilchick described as a remarkable reduction in Afib risk of approximately 44%